Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro

Molecular Medicine Reports

Volumn 8, Issue 4, 2013, Pages 1272-1278

  Yang, Lin ^a   Wu, Xiao Hou ^a   Wang, Dan ^a   Luo, Chun Li ^b   Chen, Li Xue ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bladder cancer; Exosomes; Mitogen activated protein kinase extracellular signal regulated kinase and phoshoinositide 3 kinase Akt signaling pathways; Proliferation

Indexed keywords

CASPASE 3; CYCLIN D1; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; APOPTOSIS REGULATORY PROTEIN;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL COUNT; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PROTEIN CONTENT; PROTEIN EXPRESSION; PURIFICATION; SIGNAL TRANSDUCTION; SUPERNATANT; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING; BLADDER TUMOR; CELL SURVIVAL; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

MAMMALIA;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; EXOSOMES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; PROTO-ONCOGENE PROTEINS C-AKT; URINARY BLADDER NEOPLASMS;

EID: 84883412245     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1634     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Hurst R: Does the biomarker search paradigm need re-booting? BMC Urol 9: 1, 2009.
3. Vlassov AV, Magdaleno S, Setterquist R and Conrad R: Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820: 940-948, 2012.
4. Mathivanan S, Ji H and Simpson RJ: Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73: 1907-1920, 2010.
5. Johnstone RM, Adam M, Hammond JR, et al: Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262: 9412-9420, 1987.
6. Potolicchio I, Carven GJ, Xu X, et al: Analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol 175: 2237-2243, 2005.
7. Henderson MC and Azorsa DO: The genomic and proteomic content of cancer cell-derived exosomes. Front Oncol 2: 38, 2012.
8. Taylor DD and Gercel-Taylor C: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21, 2008.
9. Rosell R, Wei J and Taron M: Circulating microRNA signatures of tumor-derived exosomes for early diagnosis of non-small-cell lung cancer. Clin Lung Cancer 10: 8-9, 2009.
10. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD and Kloecker GH: Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10: 42-46, 2009.
11. Simpson RJ, Lim JW, Moritz RL and Mathivanan S: Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 6: 267-283, 2009.
12. Ristorcelli E, Beraud E, Verrando P, Villard C, Lafitte D, Sbarra V, et al: Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J 22: 3358-3369, 2008.
13. Zhang Y, Luo CL, He BC, Zhang JM, Cheng G and Wu XH: Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. Int J Oncol 36: 133-140, 2010.
14. Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, et al: Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7: 297-303, 2001.
15. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, et al: Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295-305, 2002.
16. Yang C and Robbins PD: The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011: 842849, 2011.
17. Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y, Hou KZ, et al: Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis 41: 875-880, 2009.
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
19. Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V and Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 1: 98-110, 2011.
20. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ and Geuze HJ: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161-1172, 1996.
21. Théry C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, et al: Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 147: 599-610, 1999.
22. Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, Ruegg C and Le Pecq JB: Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 270: 211-226, 2002.
23. Koga K, Matsumoto K, Akiyoshi T, Kubo M, Yamanaka N, Tasaki A, et al: Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res 25: 3703-3707, 2005.
24. Khan S, Aspe JR, Asumen MG, Almaguel F, Odumosu O, Acevedo-Martinez S, et al: Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer 100: 1073-1086, 2009.